Health Care/Hospital
CLIMATE CHANGE AND HEALTH INEQUITY A DEADLY MIX FOR THE MOST VULNERABLE: WORLD HEART FEDERATION
GENEVA, Sept. 29, 2022 /PRNewswire/ -- On World Heart Day, the World Heart Federation (WHF) is calling for urgent action on climate change and health inequity, saying millions more lives are now at risk from cardiovascular disease, which is still the world's biggest killer. Climate change and ai...
2022-09-29 06:01
1716
ASTRUM-005: The first immunotherapy clinical study of SCLC published in JAMA, one of the top medical journals in the world
* ASTRUM-005 is the first study to demonstrate that PD-1 inhibitors plus chemotherapy can improve survival for patients with ES-SCLC. * In ASTRUM-005, serplulimab combined with chemotherapy achieved by far the longest OS in first-line immunotherapy for ES-SCLC. Compared with chemotherapy, the...
2022-09-28 21:00
1819
ICHNOS SCIENCES ANNOUNCES INITIATION OF FIRST-IN-HUMAN STUDY FOR ISB 1442
First patient dosed with novel biparatopic 2+1 BEAT® bispecific antibody targeting CD38 and CD47 NEW YORK, Sept. 28, 2022 /PRNewswire/ -- Ichnos Sciences Inc., a global clinical-stage biotechnology company developing innovative multispecific immune cell engager antibodies in oncology, today anno...
2022-09-28 20:30
1185
ABILITY DIABETES GLOBAL - A Landmark RCT in the field of PCI for patients with DM, completes Enrolment
TAMPA, Fla., Sept. 28, 2022 /PRNewswire/ -- ABILITY DIABETES-GLOBAL
2022-09-28 20:29
1660
Advanced Instruments Introduces Solentim VIPS™ PRO, A High Efficiency Single Cell Seeder to Optimize Cell Line Development Workflows
VIPS PRO delivers powerful and efficient seeding technology and definitive proof of monoclonality for workflow productivity and confidence. NORWOOD, Mass., Sept. 28, 2022 /PRNewswire/ -- Advanced Instruments today announced the launch ofSolentim VIPS PRO, a high efficiency single cell seeder, at...
2022-09-28 20:05
1628
Biosyngen Gives Cell Therapy GMP Capabilities in Singapore A Boost
SINGAPORE, Sept. 28, 2022 /PRNewswire/ -- On September 22nd, Biosyngen signed to set up a Cell Therapy GMP Facility which will serve as a base to develop the company's immunotherapy assets to address unmet needs in cancer treatment. Located in Solaris @ Tai Seng, this 1,300 square metres faci...
2022-09-28 17:34
4241
New GHA Certification Helps Medical Tourism Facilitators Build Patient Trust
WEST PALM BEACH, Fla., Sept. 28, 2022 /PRNewswire/ -- Global Healthcare Accreditation (GHA) announces the launch of a new certification program for medical travel facilitators to assist in building patient trust. GHA's Medical Travel Facilitator Certification focuses on validating the capacity ...
2022-09-28 17:00
1821
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S announce a strategic collaboration in the field of RNA-targeting small molecules in neurology
CAMBRIDGE, England and COPENHAGEN, Denmark, Sept. 28, 2022 /PRNewswire/ -- Vernalis Research ("Vernalis"), a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S ("Contera") are pleased to announce a strategic drug discovery collaboration on an undisclosed target. Under the terms of the...
2022-09-28 16:00
1429
Daiichi Sankyo joins Startup Creasphere's Program Powered by Plug and Play
MUNICH, Sept. 28, 2022 /PRNewswire/ -- Startup Creasphere, the digital healthcare platform of Plug and Play, has announced its new partnership with Daiichi Sankyo. The partnership presents itself at the height of digital innovation in health, allowing for a unique opportunity for Daiichi Sankyo t...
2022-09-28 16:00
1414
ScentAir Continues its Sustainability Initiatives to Enhance Immersive Sensory Experience
HONG KONG, Sept. 28, 2022 /PRNewswire/ -- For 25 years, ScentAir, the scent marketing leader, has been committed to enhancing environments, brands and experiences through improved air quality and the power of scent. With businesses and consumers worldwide taking part in the ScentAir experience, ...
2022-09-28 14:00
2282
Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib
The FDA has assigned a PDUFA goal date of March 29, 2023 for the NDA submission based on randomized-controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency LEIDEN, The Netherlands, Sept. 28, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharmi...
2022-09-28 13:00
1890
Chugai Pharma Taiwan Awarded at the Asia Responsible Enterprise Awards 2022 for 'Cycling for Charity' under Social Empowerment Category
SINGAPORE, Sept. 28, 2022 /PRNewswire/ -- The Asia Responsible Enterprise Awards (AREA) 2022 is pleased to honor 72 exemplary award recipients for championing ESG to build a resilient world and a sustainable future for all. The AREA is the most prominent CSR recognition program across Asia initia...
2022-09-28 12:30
1518
KOTRA Call Indonesian Companies to Boost Economic Cooperation
JAKARTA, Indonesia, Sept. 28, 2022 /PRNewswire/ -- On September 28, 2022, KOTRA, the Embassy of the Republic of Korea toIndonesia, and KADIN host the 'Indonesia-Korea Future New Industry Business Plaza 2022' at the Hotel Fairmont inJakarta. The event includes a Future Industry Cooperation Forum b...
2022-09-28 11:00
2046
ETANA HAS SECURED B ROUND FINANCING
JAKARTA, Indonesia, Sept. 28, 2022 /PRNewswire/ -- PT Etana Biotechnologies Indonesia (Etana), an Indonesian biopharmaceutical company, has secured B round of financing led by Yunfeng Capital and followed by HighLight Capital. This round of financing will be mainly used for further strengthening ...
2022-09-28 09:00
4113
Ascletis Announces Dosing of the First Patient in the Phase IIb Expansion Cohort of ASC22 (Envafolimab) for Chronic Hepatitis B Functional Cure
-- After the pre-Phase III clinical trial meeting with Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) in June 2022, the pathway to the registration, including patient population, dose, treatment duration, etc. of ASC22 (Envafolimab) for functional cure of...
2022-09-28 08:10
1915
Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate
MELBOURNE, Australia, Sept. 28, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approved a pivotal Phase III registration study that will bridge ...
2022-09-28 06:50
1350
First Patient in Australia Dosed with Illuccix® - Telix's Approved Prostate Cancer Imaging Agent
MELBOURNE, Australia, Sept. 28, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the first commercial dose inAustralia of its prostate cancer imaging agent, Illuccix® (Kit for Preparation of Ga-68 Glu-urea-Lys(ahx)-hbed-CC Injection), also known as...
2022-09-28 05:00
1804
City-first Interactive Exhibition on Health Tech "Healthcare 3.0 Concept Hub" opens its doors in Central
Industry leaders and Start-Ups discuss the Future of Healthcare and Technology
3 Health Zones across 2 stories illustrating the future of Technology and
Healthcare
Please download high-resolution images here: https://bit.ly/3LHep0x
2022-09-27 22:10
3564
CP KELCO PARTNERS WITH EXOPOLYMER TO BRING NEXT-GENERATION FUNCTIONAL BIOPOLYMERS TO MARKET
ATLANTA, Sept. 27, 2022 /PRNewswire/ -- CP Kelco, a global leader of nature-based ingredient solutions that is owned by J.M. Huber Corporation, and ExoPolymer, Inc., a biotechnology startup company focused on developing new-to-the-world, polysaccharide-based biopolymers, are excited to announce a ...
2022-09-27 21:00
1300
Metabolon Expands Data Access Strategy to Include Health for Life in Singapore (HELIOS) Study
Metabolon to collaborate with NTU Singapore's medical school to identify biomarkers for the prevention, diagnosis, and treatment of disease. MORRISVILLE, N.C., Sept. 27, 2022 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of res...
2022-09-27 19:57
1486
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 316 media titles]
2024-05-07 08:00
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 289 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 262 media titles]
2024-05-02 01:21
China-Serbia forum highlights community with shared future for mankind
[Picked up by 245 media titles]
2024-05-01 11:39
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
13580
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
9405
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
8925
